Houston Gilbert
Biogen (United States)(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Prostate Cancer Treatment and Research, Cancer Genomics and Diagnostics, Renal Diseases and Glomerulopathies, Adenosine and Purinergic Signaling
Most-Cited Works
- → Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics(2014)368 cited
- → Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma(2013)363 cited
- → Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events(2012)206 cited
- → MBASED: allele-specific expression detection in cancer tissues and cell lines(2014)155 cited
- → Current Status of Companion and Complementary Diagnostics: Strategic Considerations for Development and Launch(2017)117 cited
- → A multicenter, single‐arm, open‐label, phase 2 study of apitolisib (GDC‐0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study)(2016)96 cited
- → Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer(2014)95 cited
- → Phase I Study of DSTP3086S, an Antibody-Drug Conjugate Targeting Six-Transmembrane Epithelial Antigen of Prostate 1, in Metastatic Castration-Resistant Prostate Cancer(2019)86 cited
- → A phase Ib dose escalation study of the OX40 agonist MOXR0916 and the PD-L1 inhibitor atezolizumab in patients with advanced solid tumors.(2016)77 cited
- Resampling-Based Multiple Hypothesis Testing with Applications to Genomics: New Developments in the R/Bioconductor Package multtest(2009)